Artificial intelligence and image guidance in minimally invasive pancreatic surgery: current status and future challenges
Philip C. Müller , Suna Erdem , Christoph Kuemmerli , Joël L. Lavanchy , Marko Kraljevic , Daniel C. Steinemann , Adrian T. Billeter , Beat P. Müller
Artificial Intelligence Surgery ›› 2025, Vol. 5 ›› Issue (2) : 170 -81.
Artificial intelligence and image guidance in minimally invasive pancreatic surgery: current status and future challenges
Artificial intelligence (AI), machine learning (ML), and image guidance are increasingly being used to support surgeons in preoperative, intraoperative, and postoperative decision making and optimized patient care. Surgery is the cornerstone of curative treatment in pancreatic diseases, and a large amount of perioperative data are becoming available with the widespread application of minimally invasive surgical techniques. AI is showing promise in the prediction of malignancy and resectability from preoperative images. A further clinical focus is the prediction of postoperative complications, especially pancreatic fistula, and several AI algorithms now outperform conventional fistula risk scores. Future research will be directed toward refinement of intraoperative decision support systems, individualization of surgical training, and improvement of pre- and postoperative oncologic risk stratification to personalize the sequence of surgery and chemotherapy. This review summarizes recent developments in AI and image guidance for pancreatic surgery.
Artificial intelligence / image guidance / machine learning / pancreatic cancer / personalized medicine / pancreatic surgery
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
Ramshorst TME, van Hilst J, Bannone E, et al; 2022 first Internationally validated European Guidelines Meeting on Minimally Invasive Pancreatic Surgery and the IHPBA Innovation and Research Committees. International survey on opinions and use of robot-assisted and laparoscopic minimally invasive pancreatic surgery: 5-year follow up.HPB2024;26:63-72 |
| [5] |
der Heijde N, Vissers FL, Manzoni A, et al; European Consortium on Minimally Invasive Pancreatic Surgery. Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry.HPB2023;25:400-8 |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
McCarthy MLM, Nathaniel Rochester, Claude E. A proposal for the dartmouth summer research project on artificial intelligence.AI Magazine1995;27:4 |
| [16] |
De Simone B, Chouillard E, Gumbs AA, Loftus TJ, Kaafarani H, Catena F. Artificial intelligence in surgery: the emergency surgeon's perspective (the ARIES project).Discov Health Syst2022;1:9 PMCID:PMC9734362 |
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
Asbun HJ, Moekotte AL, Vissers FL, et al; International Study Group on Minimally Invasive Pancreas Surgery (I-MIPS). The miami international evidence-based guidelines on minimally invasive pancreas resection. Ann Surg. 2020;271:1-14. |
| [23] |
|
| [24] |
Abu Hilal M, van Ramshorst TME, Boggi U, et al; Collaborators. The Brescia internationally validated European guidelines on minimally invasive pancreatic surgery (EGUMIPS).Ann Surg2024;279:45-57 PMCID:PMC10727198 |
| [25] |
de Rooij T, van Hilst J, van Santvoort H, et al; Dutch Pancreatic Cancer Group. Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial.Ann Surg2019;269:2-9 |
| [26] |
Korrel M, Jones LR, van Hilst J, et al; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. 2023;31:100673. PMCID:PMC10339208 |
| [27] |
|
| [28] |
|
| [29] |
van Hilst J, de Rooij T, Bosscha K, et al; Dutch Pancreatic Cancer Group. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.Lancet Gastroenterol Hepatol2019;4:199-207 |
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
van Ramshorst TME, van Bodegraven EA, Zampedri P, Kasai M, Besselink MG, Abu Hilal M. Robot-assisted versus laparoscopic distal pancreatectomy: a systematic review and meta-analysis including patient subgroups.Surg Endosc2023;37:4131-43 PMCID:PMC10235152 |
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
Smits FJ, Henry AC, Besselink MG, et al; Dutch Pancreatic Cancer Group. Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial. Lancet. 2022;399:1867-75. |
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
Zwart MJW, Nota CLM, de Rooij T, et al; Dutch Pancreatic Cancer Group. Outcomes of a multicenter training program in robotic pancreatoduodenectomy (LAELAPS-3). Ann Surg. 2022;276:e886-95. |
| [71] |
|
| [72] |
|
| [73] |
Bissonnette V, Mirchi N, Ledwos N, Alsidieri G, Winkler-Schwartz A, Del Maestro RF; Neurosurgical Simulation & Artificial Intelligence Learning Centre. Artificial intelligence distinguishes surgical training levels in a virtual reality spinal task. J Bone Joint Surg Am. 2019;101:e127. PMCID:PMC7406145 |
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
/
| 〈 |
|
〉 |